Open AccessAntiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology
Author(s) -
Zoe Arvanitakis,
Ana W. Capuano,
Robin L. Brey,
Debra Fleischman,
Konstantinos Arfanakis,
Aron S. Buchman,
Julie A. Schneider,
Steven R. Levine,
David A. Bennett
Publication year - 2019
Publication title -
neuroepidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.217
H-Index - 87
eISSN - 1423-0208
pISSN - 0251-5350
DOI - 10.1159/000500157
Subject(s) - neuropathology , medicine , cognitive decline , neuroimaging , neuropsychology , dementia , cognition , disease , psychiatry
Few data are available on associations of antiphospholipid (aPL) antibodies with cognitive and motor decline in aging, and cerebrovascular disease on in vivo neuroimaging and postmortem neuropathology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom